Mohamad J. Alshikho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohamad J. Alshikho has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Jacob M. Hooker
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
3 shared publications - Marco Luciano Loggia
MGH / Harvard Medical School
3 shared publications - Nazem Atassi
Neurological Clinical Research Institute (NCRI), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
3 shared publications - Nicole R. Zurcher
Department of Radiology A.A. Martinos Center for Biomedical Imaging Massachusetts General Hospital Harvard Medical School Boston MA USA
3 shared publications - Paul Cernasov
Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
3 shared publications - Sabrina Paganoni
Neurological Clinical Research Institute and Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital Boston Massachusetts USA
3 shared publications
Latest Publications
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214220
Alzheimer Disease, Vascular Disease, and Blood-Brain Barrier Permeability Biomarkers in Middle-Aged Adults
Cerebrovascular disease (CVD) influences Alzheimer disease (AD) risk and progression, but the link between vascular disease and AD pathophysiology remains unclear, particularly in midlife when the impact of CVD on AD risk may be strongest. This study examined the relationship of recently validated vascular cognitive impairment (VCI) plasma biomarker concentrations that reflect aspects of blood-brain barrier dysfunction with MRI markers of CVD and AD plasma biomarker concentrations. The study included middle-aged participants from the Offspring Study of Racial and Ethnic Disparities in AD who had MRI and plasma biomarker data available. Biomarker concentrations of vascular endothelial growth factor (VEGF) family members (VEGF-D, placental growth factor [PlGF], and basic fibroblast growth factor [bFGF]) were measured using the Meso Scale Discovery platform. β-Amyloid (Aβ42, Aβ40), phosphorylated tau 181 (p-tau181), astrocytosis (glial fibrillary acidic protein [GFAP]), and neurodegeneration (neurofilament light chain [NfL]) biomarkers were measured with Simoa immunoassays. White matter hyperintensity (WMH) volumes were derived from T2-weighted MRI scans. Bivariate relationships of WMH, Aβ42/Aβ40 ratio, p-tau181, GFAP, and NfL with VEGF biomarkers were tested, and path analyses examined potential causal pathways linking each VEGF biomarker concentration to WMH and GFAP, as well as their downstream associations with tau pathology and neurodegeneration. We analyzed data from 488 participants (mean [SD] age = 54.3 [10.5]; 66.8% women). Higher PlGF levels were associated with older age (R [CI] = 0.25 [0.17-0.33]); greater WMH volume (R [CI] = 0.2 [0.11-0.29]); and higher levels of GFAP (R [CI] = 0.11 [0.02-0.2]), p-tau181 (R [CI] = 0.12 [0.03-0.21]), and NfL (R [CI] = 0.19 [0.1-0.27]). Higher VEGF-D was associated with increased GFAP (R [CI] = 0.11 [0.02-0.19]) and NfL (R [CI] = 0.16 [0.07-0.25]) levels. bFGF concentration was associated with a lower Aβ42/40 ratio (R [CI] = -0.1 [-0.19 to -0.02]) and higher p-tau181 levels (R [CI] = 0.13 [0.04-0.21]). The best fitting path model showed that PlGF had an indirect effect on GFAP levels mediated by WMH. GFAP subsequently had a direct positive effect on p-tau181, which in turn had a positive effect on NfL levels. VEGF-D and bFGF levels also had a positive direct effect on NfL. The findings suggest that permeability of the blood-brain barrier is linked to AD pathophysiology, contributes to cerebrovascular lesions observed on MRI, and is associated with neuroinflammation in middle age.
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214220
Alzheimer Disease, Vascular Disease, and Blood-Brain Barrier Permeability Biomarkers in Middle-Aged Adults
Cerebrovascular disease (CVD) influences Alzheimer disease (AD) risk and progression, but the link between vascular disease and AD pathophysiology remains unclear, particularly in midlife when the impact of CVD on AD risk may be strongest. This study examined the relationship of recently validated vascular cognitive impairment (VCI) plasma biomarker concentrations that reflect aspects of blood-brain barrier dysfunction with MRI markers of CVD and AD plasma biomarker concentrations. The study included middle-aged participants from the Offspring Study of Racial and Ethnic Disparities in AD who had MRI and plasma biomarker data available. Biomarker concentrations of vascular endothelial growth factor (VEGF) family members (VEGF-D, placental growth factor [PlGF], and basic fibroblast growth factor [bFGF]) were measured using the Meso Scale Discovery platform. β-Amyloid (Aβ42, Aβ40), phosphorylated tau 181 (p-tau181), astrocytosis (glial fibrillary acidic protein [GFAP]), and neurodegeneration (neurofilament light chain [NfL]) biomarkers were measured with Simoa immunoassays. White matter hyperintensity (WMH) volumes were derived from T2-weighted MRI scans. Bivariate relationships of WMH, Aβ42/Aβ40 ratio, p-tau181, GFAP, and NfL with VEGF biomarkers were tested, and path analyses examined potential causal pathways linking each VEGF biomarker concentration to WMH and GFAP, as well as their downstream associations with tau pathology and neurodegeneration. We analyzed data from 488 participants (mean [SD] age = 54.3 [10.5]; 66.8% women). Higher PlGF levels were associated with older age (R [CI] = 0.25 [0.17-0.33]); greater WMH volume (R [CI] = 0.2 [0.11-0.29]); and higher levels of GFAP (R [CI] = 0.11 [0.02-0.2]), p-tau181 (R [CI] = 0.12 [0.03-0.21]), and NfL (R [CI] = 0.19 [0.1-0.27]). Higher VEGF-D was associated with increased GFAP (R [CI] = 0.11 [0.02-0.19]) and NfL (R [CI] = 0.16 [0.07-0.25]) levels. bFGF concentration was associated with a lower Aβ42/40 ratio (R [CI] = -0.1 [-0.19 to -0.02]) and higher p-tau181 levels (R [CI] = 0.13 [0.04-0.21]). The best fitting path model showed that PlGF had an indirect effect on GFAP levels mediated by WMH. GFAP subsequently had a direct positive effect on p-tau181, which in turn had a positive effect on NfL levels. VEGF-D and bFGF levels also had a positive direct effect on NfL. The findings suggest that permeability of the blood-brain barrier is linked to AD pathophysiology, contributes to cerebrovascular lesions observed on MRI, and is associated with neuroinflammation in middle age.
- 8 May 2018
- Published by Wiley in Annals of Neurology
- Vol. 83 (6) , 1186-1197
Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
Objective: To characterize [11C]‐PBR28 brain uptake using positron emission tomography (PET) in people with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). We have previously shown increased [11C]‐PBR28 uptake in the precentral gyrus in a small group of ALS patients. Herein, we confirm our initial finding, study the longitudinal changes, and characterize the gray versus white matter distribution of [11C]‐PBR28 uptake in a larger cohort of patients with ALS and PLS.Methods: Eighty‐five participants including 53 with ALS, 11 with PLS, and 21 healthy controls underwent integrated [11C]‐PBR28 PET–magnetic resonance brain imaging. Patients were clinically assessed using the Upper Motor Neuron Burden (UMNB) and the Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R). [11C]‐PBR28 uptake was quantified as standardized uptake value ratio (SUVR) and compared between groups. Cortical thickness and fractional anisotropy were compared between groups and correlated with SUVR and the clinical data. [11C]‐PBR28 uptake and ALSFRS‐R were compared longitudinally over 6 months in 10 ALS individuals.Results: Whole brain voxelwise, surface‐based, and region of interest analyses revealed increased [11C]‐PBR28 uptake in the precentral and paracentral gyri in ALS, and in the subcortical white matter for the same regions in PLS, compared to controls. The increase in [11C]‐PBR28 uptake colocalized and correlated with cortical thinning, reduced fractional anisotropy, and increased mean diffusivity, and correlated with higher UMNB score. No significant changes were detected in [11C]‐PBR28 uptake over 6 months despite clinical progression.Interpretation: Glial activation measured by in vivo [11C]‐PBR28 PET is increased in pathologically relevant regions in people with ALS and correlates with clinical measures. Ann Neurol 2018;83:1186–1197
- 8 May 2018
- Published by Wiley in Annals of Neurology
- Vol. 83 (6) , 1186-1197
Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
Objective: To characterize [11C]‐PBR28 brain uptake using positron emission tomography (PET) in people with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). We have previously shown increased [11C]‐PBR28 uptake in the precentral gyrus in a small group of ALS patients. Herein, we confirm our initial finding, study the longitudinal changes, and characterize the gray versus white matter distribution of [11C]‐PBR28 uptake in a larger cohort of patients with ALS and PLS.Methods: Eighty‐five participants including 53 with ALS, 11 with PLS, and 21 healthy controls underwent integrated [11C]‐PBR28 PET–magnetic resonance brain imaging. Patients were clinically assessed using the Upper Motor Neuron Burden (UMNB) and the Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R). [11C]‐PBR28 uptake was quantified as standardized uptake value ratio (SUVR) and compared between groups. Cortical thickness and fractional anisotropy were compared between groups and correlated with SUVR and the clinical data. [11C]‐PBR28 uptake and ALSFRS‐R were compared longitudinally over 6 months in 10 ALS individuals.Results: Whole brain voxelwise, surface‐based, and region of interest analyses revealed increased [11C]‐PBR28 uptake in the precentral and paracentral gyri in ALS, and in the subcortical white matter for the same regions in PLS, compared to controls. The increase in [11C]‐PBR28 uptake colocalized and correlated with cortical thinning, reduced fractional anisotropy, and increased mean diffusivity, and correlated with higher UMNB score. No significant changes were detected in [11C]‐PBR28 uptake over 6 months despite clinical progression.Interpretation: Glial activation measured by in vivo [11C]‐PBR28 PET is increased in pathologically relevant regions in people with ALS and correlates with clinical measures. Ann Neurol 2018;83:1186–1197
- Open Access
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 20, 357-364
Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 20, 357-364
Open AccessIntegrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis
- Open Access
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 17, 347-353
Imaging of glia activation in people with primary lateral sclerosis
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 17, 347-353
Open AccessImaging of glia activation in people with primary lateral sclerosis
- 1 September 2016
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 97 (9) , 1487-1495
Correlation of Fractional Anisotropy With Motor Recovery in Patients With Stroke After Postacute Rehabilitation
- 1 September 2016
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 97 (9) , 1487-1495
Correlation of Fractional Anisotropy With Motor Recovery in Patients With Stroke After Postacute Rehabilitation
- Open Access
- 21 July 2016
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 17, 512-522
Intestinal Lymphangiectasia: Insights on Management and Literature Review
BACKGROUND:Intestinal lymphangiectasia (IL) is a rare disease characterized by a dilatation of the intestinal lymphatics and loss of lymph fluid into the gastrointestinal tract leading to hypoproteinemia, edema, lymphocytopenia, hypogammaglobinemia, ...
- 21 July 2016
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 17, 512-522
Open AccessIntestinal Lymphangiectasia: Insights on Management and Literature Review
BACKGROUND:Intestinal lymphangiectasia (IL) is a rare disease characterized by a dilatation of the intestinal lymphatics and loss of lymph fluid into the gastrointestinal tract leading to hypoproteinemia, edema, lymphocytopenia, hypogammaglobinemia, ...
- Open Access
- 13 June 2016
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 17, 398-405
Zollinger-Ellison Syndrome Associated with von Recklinghausen Disease: Case Report and Literature Review
BACKGROUND:Pancreatic endocrine tumors (PETs) are rare and can occur as part of neurofibromatosis type 1 (NF1). Gastrinomas are functional PETs that are rarely associated with NF1. Only two cases of their occurrence have been reported in the literatu...
- 13 June 2016
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 17, 398-405
Open AccessZollinger-Ellison Syndrome Associated with von Recklinghausen Disease: Case Report and Literature Review
BACKGROUND:Pancreatic endocrine tumors (PETs) are rare and can occur as part of neurofibromatosis type 1 (NF1). Gastrinomas are functional PETs that are rarely associated with NF1. Only two cases of their occurrence have been reported in the literatu...